Test Questions

Ovarian Cancer: One of the Common Gynecologic Malignancies

Exam Questions

1. A woman's risk of developing ovarian cancer in her lifetime is:
    A. 0.5%
    B. 1.7%
    C. 5.3%
    D. 8.4%
2. Risk factors for ovarian cancer include:
    A. Environmental factors
    B. Genetic factors
    C. Reproductive factors
    D. All of the above
3. Which factor significantly decreases a woman's risk of ovarian cancer?
    A. Birth of a child
    B. Hormone replacement therapy (HRT)
    C. Late menopause
    D. Weight loss
4. The most common type of ovarian cancer is:
    A. Adenocarcinoma
    B. Epithelial
    C. Germ cell
    D. Squamous cell
5. Symptoms of ovarian cancer include:
    A. Abdominal pain
    B. Bloating
    C. Difficulty eating
    D. All of the above
6. Which of the following is an effective screening tool for ovarian cancer?
    A. Annual Pap smear
    B. Cancer antigen (CA) 125
    C. Ultrasound
    D. No effective screening tool currently exists
7. The percentage of women presenting with late-stage ovarian cancer is:
    A. 25%
    B. 50%
    C. 70%
    D. 95%
8. Chemoprevention to reduce the risk of ovarian cancer includes:
    A. Arimidex
    B. HRT
    C. Oral contraceptives
    D. Tamoxifen
9. Outcome studies suggest that the mass found in ovarian cancer should be removed by a:
    A. General surgeon
    B. Gynecologic oncologist
    C. Medical oncologist
    D. All of the above
10. The percentage of patients cured of early-stage ovarian cancer is:
    A. 0% to 20%
    B. 30% to 50%
    C. 70% to 90%
    D. 95% to 100%
11. Adjuvant chemotherapy for unfavorable early-stage ovarian cancer consists of:
    A. Carboplatin and paclitaxel
    B. Docetaxel and prednisone
    C. Doxorubicin and cyclophosphamide
    D. Oxaliplatin and fluorouracil
12. Clinical studies suggest that intraperitoneal (IP) chemotherapy should be used in:
    A. Stage I disease
    B. Stage II disease
    C. Stage III disease
    D. Stage IV disease
13. Disease response is often monitored by:
    A. CA 15-3
    B. CA 19-9
    C. CA-125
    D. Carcinoembryonic antigen
14. Women with recurrence within 6 months after receiving carboplatin and paclitaxel are considered to have disease that is:
    A. Platinum-sensitive
    B. Platinum-resistant
    C. Taxane-sensitive
    D. Taxane-resistant
15. Clinical trials of bevacizumab in the treatment of ovarian cancer have found an increase in:
    A. Congestive heart failure
    B. Gastrointestinal perforation
    C. Rash
    D. Stomatitis
16. Premedication for paclitaxel should include:
    A. Acetaminophen
    B. Dexamethasone
    C. Ibuprofen
    D. Meperidine
17. Which of the following drug(s) need(s) to be placed in a non–polyvinyl chloride (PVC) bag?
    A. Carboplatin
    B. Cisplatin
    C. Paclitaxel
    D. All of the above
18. Which statement is true?
    A. Carboplatin hypersensitivity reactions frequently occur with the first cycle of carboplatin.
    B. A patient experiencing a carboplatin hypersensitivity reaction rarely requires medical attention.
    C. A patient who experiences a carboplatin hypersensitivity reaction should never receive another dose of carboplatin.
    D. Carboplatin hypersensitivity reactions frequently occur after 4 to 6 cycles of carboplatin.
19. Which of the following regimens constitutes the most appropriate antiemetic therapy for carboplatin and paclitaxel?
    A. Dexamethasone and ondansetron
    B. Ondansetron alone
    C. Prochlorperazine alone
    D. Nothing required, since patient should be receiving dexamethasone for paclitaxel hypersensitivity
20. The correct dose of carboplatin in order to achieve an AUC of 6.0 in a patient with a creatinine clearance of 80 mL/minute is:
    A. 230 mg
    B. 505 mg
    C. 630 mg
    D. 840 mg

Evaluation Questions

21. Met objective 1:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
22. Met objective 2:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
23. Met objective 3:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
    F. N/A for Pharmacy Technicians
24. Met objective 4:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
25. Related to your educational needs:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
26. The active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
27. Avoided commercial bias:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
28. How would you rate the overall usefulness of the material presented?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
29. How would you rate the quality of the faculty?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
30. How would you rate the appropriateness of the examination for this activity?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
31. Comments on this program:
 
* Also applies to pharmacy technicians